Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults.

Marcial GE, Ford AL, Haller MJ, Gezan SA, Harrison NA, Cai D, Meyer JL, Perry DJ, Atkinson MA, Wasserfall CH, Garrett T, Gonzalez CF, Brusko TM, Dahl WJ, Lorca GL.

Front Immunol. 2017 Jun 12;8:655. doi: 10.3389/fimmu.2017.00655. eCollection 2017.

2.

Lactobacillus johnsonii N6.2 diminishes caspase-1 maturation in the gastrointestinal system of diabetes prone rats.

Teixeira LD, Kling DN, Lorca GL, Gonzalez CF.

Benef Microbes. 2018 Apr 25;9(3):527-539. doi: 10.3920/BM2017.0120. Epub 2018 Apr 10.

PMID:
29633641
3.

Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.

Valladares R, Sankar D, Li N, Williams E, Lai KK, Abdelgeliel AS, Gonzalez CF, Wasserfall CH, Larkin J, Schatz D, Atkinson MA, Triplett EW, Neu J, Lorca GL.

PLoS One. 2010 May 6;5(5):e10507. doi: 10.1371/journal.pone.0010507.

4.

Lactobacillus johnsonii inhibits indoleamine 2,3-dioxygenase and alters tryptophan metabolite levels in BioBreeding rats.

Valladares R, Bojilova L, Potts AH, Cameron E, Gardner C, Lorca G, Gonzalez CF.

FASEB J. 2013 Apr;27(4):1711-20. doi: 10.1096/fj.12-223339. Epub 2013 Jan 9.

PMID:
23303207
5.

H2O2 production rate in Lactobacillus johnsonii is modulated via the interplay of a heterodimeric flavin oxidoreductase with a soluble 28 Kd PAS domain containing protein.

Valladares RB, Graves C, Wright K, Gardner CL, Lorca GL, Gonzalez CF.

Front Microbiol. 2015 Jul 14;6:716. doi: 10.3389/fmicb.2015.00716. eCollection 2015.

6.

Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment.

Ekmekciu I, von Klitzing E, Neumann C, Bacher P, Scheffold A, Bereswill S, Heimesaat MM.

Front Microbiol. 2017 Dec 11;8:2430. doi: 10.3389/fmicb.2017.02430. eCollection 2017.

7.

Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1.

Yamano T, Iino H, Takada M, Blum S, Rochat F, Fukushima Y.

Br J Nutr. 2006 Feb;95(2):303-12.

PMID:
16469146
8.

Lactobacillus johnsonii N6.2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats.

Kingma SD, Li N, Sun F, Valladares RB, Neu J, Lorca GL.

J Nutr. 2011 Jun;141(6):1023-8. doi: 10.3945/jn.110.135517. Epub 2011 Apr 13.

PMID:
21490291
9.

Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults.

Sierra S, Lara-Villoslada F, Sempere L, Olivares M, Boza J, Xaus J.

Anaerobe. 2010 Jun;16(3):195-200. doi: 10.1016/j.anaerobe.2010.02.001. Epub 2010 Feb 14.

PMID:
20159049
10.

Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults.

Hanifi A, Culpepper T, Mai V, Anand A, Ford AL, Ukhanova M, Christman M, Tompkins TA, Dahl WJ.

Benef Microbes. 2015 Mar;6(1):19-27. doi: 10.3920/BM2014.0031.

PMID:
25062611
11.

Blueberries as an additive to increase the survival of Lactobacillus johnsonii N6.2 to lyophilisation.

Cai D, Harrison NA, Kling DN, Gonzalez CF, Lorca GL.

Benef Microbes. 2019 Apr 1:1-10. doi: 10.3920/BM2018.0144. [Epub ahead of print]

PMID:
30931589
12.

Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias.

Lau K, Benitez P, Ardissone A, Wilson TD, Collins EL, Lorca G, Li N, Sankar D, Wasserfall C, Neu J, Atkinson MA, Shatz D, Triplett EW, Larkin J 3rd.

J Immunol. 2011 Mar 15;186(6):3538-46. doi: 10.4049/jimmunol.1001864. Epub 2011 Feb 11.

13.

Indication for Co-evolution of Lactobacillus johnsonii with its hosts.

Buhnik-Rosenblau K, Matsko-Efimov V, Jung M, Shin H, Danin-Poleg Y, Kashi Y.

BMC Microbiol. 2012 Jul 25;12:149. doi: 10.1186/1471-2180-12-149.

15.

Probiotic Lactobacillus johnsonii BS15 Promotes Growth Performance, Intestinal Immunity, and Gut Microbiota in Piglets.

Xin J, Zeng D, Wang H, Sun N, Zhao Y, Dan Y, Pan K, Jing B, Ni X.

Probiotics Antimicrob Proteins. 2019 Jan 7. doi: 10.1007/s12602-018-9511-y. [Epub ahead of print]

PMID:
30617949
16.

Predominant effect of host genetics on levels of Lactobacillus johnsonii bacteria in the mouse gut.

Buhnik-Rosenblau K, Danin-Poleg Y, Kashi Y.

Appl Environ Microbiol. 2011 Sep;77(18):6531-8. doi: 10.1128/AEM.00324-11. Epub 2011 Jul 29.

18.

Sex Modulates Lactobacillus johnsonii N6.2 and Phytophenol Effectiveness in Reducing High Fat Diet Induced mTOR Activation in Sprague-Dawley Rats.

Kling DN, DeBose-Scarlett EM, Teixeira LD, Gezan SA, Lorca GL, Gonzalez CF.

Front Microbiol. 2018 Nov 6;9:2649. doi: 10.3389/fmicb.2018.02649. eCollection 2018.

19.

Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study.

Jespersen L, Tarnow I, Eskesen D, Morberg CM, Michelsen B, Bügel S, Dragsted LO, Rijkers GT, Calder PC.

Am J Clin Nutr. 2015 Jun;101(6):1188-96. doi: 10.3945/ajcn.114.103531. Epub 2015 Apr 29.

PMID:
25926507
20.

A mixture of Lactobacillus plantarum CECT 7315 and CECT 7316 enhances systemic immunity in elderly subjects. A dose-response, double-blind, placebo-controlled, randomized pilot trial.

Mañé J, Pedrosa E, Lorén V, Gassull MA, Espadaler J, Cuñé J, Audivert S, Bonachera MA, Cabré E.

Nutr Hosp. 2011 Jan-Feb;26(1):228-35.

Supplemental Content

Support Center